PubMedCrossRef 27. Abreu MT, Fukata M, Arditi M: TLR signaling in the gut in health and disease. J Immunol 2005,174(8):4453–4460.PubMed 28. Beutler B, Poltorak A: The sole gateway to endotoxin response: how LPS was identified

as Tlr4, and its role in innate immunity. Drug Metab Dispos 2001, 29:(4 Pt 2):474–478. buy AZD1390 29. Weiss DS, Raupach B, Takeda K, Akira S, Zychlinsky A: Toll-like receptors are temporally involved in host defense. J Immunol 2004,172(7):4463–4469.PubMed 30. van Bruggen R, Zweers D, van Diepen A, van Dissel JT, Roos D, Verhoeven AJ, Kuijpers TW: Complement receptor 3 and Toll-like receptor 4 act sequentially in uptake and intracellular killing of unopsonized Salmonella enterica serovar Typhimurium by human neutrophils. Infect Immun

2007,75(6):2655–2660.PubMedCrossRef BLZ945 mouse 31. Duerr CU, Zenk SF, Chassin C, Pott J, Gutle D, Hensel M, Hornef MW: O-antigen delays lipopolysaccharide recognition and impairs antibacterial host defense in murine intestinal epithelial cells. PLoS Pathog 2009, 5:(9):e1000567.PubMedCrossRef 32. Totemeyer S, Foster N, Kaiser P, Maskell DJ, Bryant CE: Toll-like receptor expression in C3H/HeN and C3H/HeJ mice during Salmonella enterica serovar Typhimurium infection. Infect Immun 2003,71(11):6653–6657.PubMedCrossRef 33. Gribar SC, Richardson WM, Sodhi CP, Hackam DJ: No longer an innocent bystander: epithelial toll-like receptor signaling in the development of mucosal inflammation. Mol Med 2008, 14:(9–10):645–659.PubMed 34. Fournier B, Williams IR, Gewirtz AT, Neish AS: Toll-like receptor 5-dependent regulation of inflammation in systemic Salmonella enterica Serovar typhimurium infection. Infect Immun 2009,77(9):4121–4129.PubMedCrossRef RANTES 35. Vijay-Kumar M, Sanders CJ, Taylor RT, Kumar A, Aitken JD, Sitaraman SV, Neish AS, Uematsu S, Akira S, Williams IR, et al.: Deletion of TLR5 results in STI571 molecular weight spontaneous colitis in mice. J Clin Invest 2007,117(12):3909–3921.PubMed 36. Gramzinski RA, Doolan DL, Sedegah M, Davis HL, Krieg AM, Hoffman

SL: Interleukin-12- and gamma interferon-dependent protection against malaria conferred by CpG oligodeoxynucleotide in mice. Infect Immun 2001,69(3):1643–1649.PubMedCrossRef 37. Juffermans NP, Leemans JC, Florquin S, Verbon A, Kolk AH, Speelman P, van Deventer SJ, van der Poll T: CpG oligodeoxynucleotides enhance host defense during murine tuberculosis. Infect Immun 2002,70(1):147–152.PubMedCrossRef 38. Olbrich AR, Schimmer S, Dittmer U: Preinfection treatment of resistant mice with CpG oligodeoxynucleotides renders them susceptible to friend retrovirus-induced leukemia. J Virol 2003,77(19):10658–10662.PubMedCrossRef 39. Lavelle EC, Murphy C, O’Neill LA, Creagh EM: The role of TLRs, NLRs, and RLRs in mucosal innate immunity and homeostasis. Mucosal Immunol 2010,3(1):17–28.PubMedCrossRef 40. Dogi CA, Weill F, Perdigon G: Immune response of non-pathogenic gram(+) and gram(-) bacteria in inductive sites of the intestinal mucosa study of the pathway of signaling involved.